Fair Isaac (FICO) vs HealthEquity (HQY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
HealthEquity (HQY) has outperformed Fair Isaac (FICO) over the past year, losing 7.0% versus a loss of 61.2%. Over five years, FICO leads with a +100.9% price change compared with +65.1% for HQY. Fair Isaac is the larger company by market cap ($14.84 billion vs $7.84 billion), about 1.9 times the size.
On valuation, Fair Isaac trades at a lower forward P/E (13.6x vs 17.2x for HealthEquity). Fair Isaac converts more of its revenue into profit, with a net margin of 32.9% versus 16.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FICO | HQY |
|---|---|---|
| Share price | $694.31 | $94.75 |
| Market cap | $14.84B | $7.84B |
| 1-day change | +2.46% | -2.70% |
| YTD return | -58.93% | +3.43% |
| 1-year return | -61.17% | -7.03% |
| 5-year return | +100.89% | +65.10% |
| P/E ratio (TTM) | 19.12 | 34.21 |
| Forward P/E | 13.63 | 17.17 |
| EPS (TTM) | $36.32 | $2.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.53B | $1.31B |
| Revenue growth (YoY) | +27.32% | +9.47% |
| Net income (latest FY) | $834.97M | $215.20M |
| Gross margin | 86.13% | 69.52% |
| Operating margin | 49.93% | 24.55% |
| Net margin | 32.94% | 16.38% |
| 52-week high | $1,858.91 | $110.26 |
| 52-week low | $586.05 | $72.76 |
| Distance from 52-week high | -62.65% | -14.07% |
| Analyst consensus | buy | none |
| Avg. price target upside | +18.30% | +27.36% |
| Average volume | 805.56K | 886.63K |
| Shares outstanding | 21.38M | 82.72M |
| Employees | 3,747 | 2,814 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Business Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HQY has outperformed FICO by 54.1 percentage points over the past year.
- HealthEquity trades at a higher earnings multiple (34.2x vs 19.1x trailing P/E).
- Fair Isaac is more profitable, keeping 32.9 cents of every revenue dollar as net income versus 16.4 cents for HealthEquity.
- Fair Isaac grew revenue faster in its latest fiscal year (+27.32% vs +9.47%).
About Fair Isaac
FICO stock →Fair Isaac Corporation provides analytics software in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Scores and Software.
Consumer Discretionary · Business Services · 3,747 employees
About HealthEquity
HQY stock →HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
Consumer Discretionary · Business Services · 2,814 employees
FICO vs HQY FAQ
Which is bigger, Fair Isaac or HealthEquity?
Fair Isaac (FICO) is larger, with a market capitalization of $14.84B compared with $7.84B for HealthEquity (HQY).
Which stock has performed better over the past year, FICO or HQY?
HQY returned -7.03% over the past 12 months, compared with -61.17% for FICO (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, FICO or HQY?
FICO has the lower trailing P/E at 19.1, versus 34.2 for HQY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Fair Isaac and HealthEquity in the same industry?
Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.